Figure 3
From: Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
MEK1 mutation classification based on the functional impact. (A) MEK1 mutation classification based on the functional impact in pancancer. (B) MEK1 mutation classification based on the functional impact on all and top 12 tumors.
